Elena Diez Cecilia
Elena Diez Cecilia, Ph.D., MBA. Director of BD and R&D Strategy at A2A Pharmaceuticals, NYC, USA. Elena has worked in drug development in the USA, CAN and EU markets, to treat Cancer and Neurological diseases. Elena has consulted for tier-1 pharma companies and managed projects for a Venture Capital firm and several innovation organizations, including the Canadian CTA program and EU Horizon 2020.